NCT03575676View on ClinicalTrials.gov

Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

August 22, 2019

Study Completion Date

August 22, 2019

Conditions
Huntington's Chorea
Interventions
DRUG

SOM3355 100mg BID

Oral

DRUG

SOM3355 200mg BID

Oral

DRUG

Placebo BID

Oral

Trial Locations (4)

Unknown

Hospital Clínic de Barcelona, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

SOM Innovation Biotech SA

INDUSTRY

NCT03575676 - Efficacy and Safety of SOM3355 in Huntington's Disease Chorea | Biotech Hunter | Biotech Hunter